BACKGROUND: Individuals with allergies have a heightened Th2 (T helper 2) immunity, which may provide advantages in controlling tumor growth. Inverse associations have been reported among individuals with allergies and risk of brain and pancreatic cancers. METHODS: We examined the relationship between allergies and risk of head and neck squamous cell carcinoma (HNSCC) in a population-based case-control study with 1,014 cases and 1,193 frequency-matched controls. Logistic regression models were used to estimate odds ratios (OR) and 95 % confidence intervals (95 % CI) controlling for age, sex, race, smoking history, alcohol consumption, and education. In addition, in a subset of the population, models were adjusted for HPV16 status. RESULTS: Individuals with allergies had a 19 % lower risk of HNSCC (OR = 0.81, 95 % CI = 0.67-0.98). Associations with allergies were stronger for laryngeal (OR = 0.66, 95 % CI = 0.45-0.97) and oropharyngeal (OR = 0.73, 95 % CI = 0.57-0.92) cancers, while no association was observed for oral cavity cancers (OR = 0.98, 95 % CI = 0.76-1.26). History of asthma was not associated with overall HNSCC, but the association was statistically significant for oropharyngeal cancer (OR = 0.67, 95 % CI = 0.44-0.99). HPV16 status did not confound or modify the associations with allergies. CONCLUSIONS: Elevated Th2 immunity in individuals with history of allergies and asthma may reduce the risk of HNSCC. Additional research into related mechanisms may provide new insights into how to treat HNSCC. IMPACT: These findings may provide new insight into biological pathways that could lead to a better understanding of the etiology of this disease.
BACKGROUND: Individuals with allergies have a heightened Th2 (T helper 2) immunity, which may provide advantages in controlling tumor growth. Inverse associations have been reported among individuals with allergies and risk of brain and pancreatic cancers. METHODS: We examined the relationship between allergies and risk of head and neck squamous cell carcinoma (HNSCC) in a population-based case-control study with 1,014 cases and 1,193 frequency-matched controls. Logistic regression models were used to estimate odds ratios (OR) and 95 % confidence intervals (95 % CI) controlling for age, sex, race, smoking history, alcohol consumption, and education. In addition, in a subset of the population, models were adjusted for HPV16 status. RESULTS: Individuals with allergies had a 19 % lower risk of HNSCC (OR = 0.81, 95 % CI = 0.67-0.98). Associations with allergies were stronger for laryngeal (OR = 0.66, 95 % CI = 0.45-0.97) and oropharyngeal (OR = 0.73, 95 % CI = 0.57-0.92) cancers, while no association was observed for oral cavity cancers (OR = 0.98, 95 % CI = 0.76-1.26). History of asthma was not associated with overall HNSCC, but the association was statistically significant for oropharyngeal cancer (OR = 0.67, 95 % CI = 0.44-0.99). HPV16 status did not confound or modify the associations with allergies. CONCLUSIONS: Elevated Th2 immunity in individuals with history of allergies and asthma may reduce the risk of HNSCC. Additional research into related mechanisms may provide new insights into how to treat HNSCC. IMPACT: These findings may provide new insight into biological pathways that could lead to a better understanding of the etiology of this disease.
Authors: Tim Waterboer; Peter Sehr; Kristina M Michael; Silvia Franceschi; John D Nieland; Thomas O Joos; Markus F Templin; Michael Pawlita Journal: Clin Chem Date: 2005-08-11 Impact factor: 8.327
Authors: Michelle C Turner; Yue Chen; Daniel Krewski; Parviz Ghadirian; Michael J Thun; Eugenia E Calle Journal: Am J Epidemiol Date: 2005-06-29 Impact factor: 4.897
Authors: Sara Gandini; Albert B Lowenfels; Elizabeth M Jaffee; Todd D Armstrong; Patrick Maisonneuve Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-08 Impact factor: 4.254
Authors: C Neuchrist; J Kornfehl; M Grasl; H Lassmann; D Kraft; K Ehrenberger; O Scheiner Journal: Int Arch Allergy Immunol Date: 1994-05 Impact factor: 2.749
Authors: Filippos T Filippidis; Stephen M Schwartz; Nikolaus Becker; Gerhard Dyckhoff; Michael Kirschfink; Andreas Dietz; Heiko Becher; Heribert Ramroth Journal: Eur Arch Otorhinolaryngol Date: 2015-01-30 Impact factor: 2.503
Authors: Dominique S Michaud; Scott M Langevin; Melissa Eliot; Heather H Nelson; Michael Pawlita; Michael D McClean; Karl T Kelsey Journal: Int J Cancer Date: 2014-03-07 Impact factor: 7.396
Authors: Marni Stott-Miller; Chu Chen; David R Doody; Joseph L Carter; Denise A Galloway; Margaret M Madeleine; Stephen M Schwartz Journal: Cancer Causes Control Date: 2012-09-26 Impact factor: 2.506